Global Antibody Production Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Antibody Production Market is presumed to reach the market size of nearly USD 71.49 Billion by 2032 from USD 23.09 Billion in 2023 with a CAGR of 13.38% under the study period 2024-2032.

Antibody production is a biotechnological process wherein specific antibodies are generated for diagnostic, therapeutic, or research purposes. This involves immunizing animals or using cell cultures to elicit an immune response, which is then harvested to obtain antibodies targeting particular antigens. These antibodies, also known as immunoglobulins, are pivotal in detecting diseases, conducting research, and developing targeted treatments. Advanced techniques such as monoclonal antibody technology allow for the creation of highly specific antibodies, which are critical in advancing medical science and personalized medicine.

MARKET DYNAMICS

The rising prevalence of infections, viruses, and other diseases like cancer, rheumatoid and chronic diseases are factors driving the market growth of antibody production. Growing investments by medical research centers for research and development projects and technological advancements for new launches are expected to propel the market growth of antibody production. Numerous pharmaceuticals are shifting towards biopharma which may drive the market growth of antibody production. Furthermore, the growing use of targeted therapies is anticipated to expand the overall market growth of antibody production. The rise in government incentives for antibody production is projected to drive market growth. On the contrary, the overall cost of antibody production and strict government policies for the approval of the therapies and drugs may further hamper the market growth of antibody production.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Antibody Production. The growth and trends of Antibody Production industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Antibody Production market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Instruments (Bioreactors (Multi-Use Bioreactors, Single-Use Bioreactors), Chromatography Systems, Filtration Systems)
Consumables (Media, Buffers and Reagents, Chromatography Resins and Columns, Filtration Consumables and Accessories, Others)
Software

By Process

Upstream Processing
Downstream Processing

By Type

Monoclonal Antibody
Polyclonal Antibody

By End-use

Pharmaceutical and Biotechnology Companies
Research Laboratories
CROs and CDMOs

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Antibody Production market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Antibody Production market include Illumina Inc., Thermo Fisher Scientific Inc., Pacific Biosciences Of California Inc., BGI, QIAGEN, Agilent Technologies, PerkinElmer Inc., ProPhase Labs Inc., Psomagen, Azenta US Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112110211

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ANTIBODY PRODUCTION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Process
- 3.7.3 Market Attractiveness Analysis By Type
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANTIBODY PRODUCTION MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Instruments (Bioreactors (Multi-Use Bioreactors, Single-Use Bioreactors), Chromatography Systems, Filtration Systems) Historic and Forecast Sales By Regions
5.4. Consumables (Media, Buffers and Reagents, Chromatography Resins and Columns, Filtration Consumables and Accessories, Others) Historic and Forecast Sales By Regions
5.5. Software Historic and Forecast Sales By Regions

6. GLOBAL ANTIBODY PRODUCTION MARKET ANALYSIS BY PROCESS

6.1. Overview By Process
6.2. Historical and Forecast Data Analysis By Process
6.3. Upstream Processing Historic and Forecast Sales By Regions
6.4. Downstream Processing Historic and Forecast Sales By Regions

7. GLOBAL ANTIBODY PRODUCTION MARKET ANALYSIS BY TYPE

7.1. Overview By Type
7.2. Historical and Forecast Data Analysis By Type
7.3. Monoclonal Antibody Historic and Forecast Sales By Regions
7.4. Polyclonal Antibody Historic and Forecast Sales By Regions

8. GLOBAL ANTIBODY PRODUCTION MARKET ANALYSIS BY END-USE

8.1. Overview By End-use
8.2. Historical and Forecast Data Analysis By End-use
8.3. Pharmaceutical and Biotechnology Companies Historic and Forecast Sales By Regions
8.4. Research Laboratories Historic and Forecast Sales By Regions
8.5. CROs and CDMOs Historic and Forecast Sales By Regions

9. GLOBAL ANTIBODY PRODUCTION MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ANTIBODY PRODUCTION COMPANIES

10.1. Antibody Production Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF ANTIBODY PRODUCTION INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Illumina Inc.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Thermo Fisher Scientific Inc.
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Pacific Biosciences Of California Inc.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. BGI
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. QIAGEN
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Agilent Technologies
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. PerkinElmer Inc.
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. ProPhase Labs Inc.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Psomagen
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Azenta US Inc
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies